Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.94
BATS BZX Real-Time Price
As of 2:25pm ET
 +0.26 / +3.89%
Today’s Change
5.85
Today|||52-Week Range
11.69
0.00%
Year-to-Date
Biotech Movers: Cempra Flys High On Phase Three Results
Feb 24 / TheStreet.com - Paid Partner Content
Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals
Feb 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.68
Today’s open6.85
Day’s range6.74 - 6.99
Volume40,663
Average volume (3 months)975,780
Market cap$494.7M
Dividend yield--
Data as of 2:25pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.41+3.54%
SCLNSciClone Pharmaceuti...+0.20+2.07%
CRHMCRH Medical Corp-0.13-1.78%
RARXRa Pharmaceuticals I...-0.04-0.19%
Data as of 2:23pm ET, 02/27/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts


Search for Jobs